Search: onr:"swepub:oai:DiVA.org:uu-460718" >
Fludarabine and Mel...
-
Oran, BetulUniv Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Div Canc Med, Houston, TX 77030 USA.
(author)
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
- Article/chapterEnglish2021
Publisher, publication year, extent ...
-
Elsevier,2021
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-460718
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-460718URI
-
https://doi.org/10.1016/j.jtct.2021.08.007DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:148159287URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Reduced-intensity conditioning (RIC) regimens developed to extend the use of allogeneic hematopoietic stem cell transplantation (HSCT) to older patients have resulted in encouraging outcomes. We aimed to compare the 2 most commonly used RIC regimens, i.v. fludarabine with busulfan (FluBu) and fludarabine with melphalan (FluMel), in patients with myelodysplastic syndrome (MDS). Through the Center for International Blood and Marrow Transplant Research (CIBMTR), we identified 1045 MDS patients age >= 60 years who underwent first HSCT with a matched related or matched (8/8) unrelated donor using an RIC regimen. The CIBMTR's definition of RIC was used: a regimen that incorporated an i.v. busulfan total dose <= 7.2 mg/kg or a low-dose melphalan total dose <= 150 mg/m(2). The 2 groups, recipients of FluBu (n = 697) and recipients of FluMel (n = 448), were comparable in terms of disease- and transplantation-related characteristics except for the more frequent use of antithymocyte globulin or alemtuzumab in the FluBu group (39% versus 31%). The median age was 67 years in both groups. FluMel was associated with a reduced relapse incidence (RI) compared with FluBu, with a 1-year adjusted incidence of 26% versus 44% (P <=.0001). Transplantation-related mortality (TRM) was higher in the FluMel group (26% versus 16%; P <= .0001). Because the magnitude of improvement with FluMel in RI was greater than the improvement in TRM with FluBu, disease-free survival (DFS) was better at 1 year and beyond with FluMel compared with FluBu (48% versus 40% at 1 year [P =.02] and 35% versus 27% at 3 years [P =.01]). Overall survival was comparable in the 2 groups at 1 year (63% versus 61%; P =.4) but was significantly improved with FluMel compared with FluBu at 3 years (46% versus 39%; P =.03). Our results suggest that FluMel is associated with superior DFS compared with FluBu owing to reduced RI in older patients with MDS patients.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Ahn, Kwang WooMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA.
(author)
-
Fretham, CaitrinCtr Int Blood & Marrow Transplant Res, Natl Marrow Donor Program Be The Match, Minneapolis, MN USA.
(author)
-
Beitinjaneh, AmerUniv Miami, Div Transplantat & Cellular Therapy, Miami, FL USA.
(author)
-
Bashey, AsadUniv Miami, Div Transplantat & Cellular Therapy, Miami, FL USA.
(author)
-
Pawarode, AttapholUniv Michigan, Sch Med, Dept Internal Med, Blood & Marrow Transplantat Program,Div Hematol O, Ann Arbor, MI USA.
(author)
-
Wirk, BaldeepPenn State Canc Inst, Bone Marrow Transplant Program, Hershey, PA USA.
(author)
-
Scott, Bart L.Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
(author)
-
Savani, Bipin N.Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA.
(author)
-
Bredeson, ChristopherOttawa Hosp, Blood & Marrow Transplant Program, Ottawa, ON, Canada.;Ottawa Hosp Res Inst, Ottawa, ON, Canada.
(author)
-
Weisdorf, DanielUniv Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.
(author)
-
Marks, David I.Univ Hosp Bristol NHS Trust, Adult Bone Marrow Transplant, Bristol, Avon, England.
(author)
-
Rizzieri, DavidDuke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA.
(author)
-
Copelan, EdwardAtrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA.
(author)
-
Hildebrandt, Gerhard C.Univ Kentucky, Markey Canc Ctr, Lexington, KY USA.
(author)
-
Hale, Gregory A.Johns Hopkins All Childrens Hosp, Dept Hematol Oncol, St Petersburg, FL USA.
(author)
-
Murthy, Hemant S.Mayo Clin, Div Hematol Oncol, Blood & Marrow Transplantat Program, Jacksonville, FL 32224 USA.
(author)
-
Lazarus, Hillard M.Case Western Reserve Univ, Univ Hosp Cleveland Med Ctr, Cleveland, OH 44106 USA.
(author)
-
Cerny, JanUniv Massachusetts, Med Ctr, Dept Med, Div Hematol Oncol, Worcester, MA USA.
(author)
-
Liesveld, Jane L.Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.
(author)
-
Yared, Jean A.Univ Maryland, Dept Med, Greenebaum Comprehens Canc Ctr, Blood & Marrow Transplantat Program,Div Hematol O, Baltimore, MD 21201 USA.
(author)
-
Yves-Cahn, JeanCHU Grenoble Alpes, Dept Hematol, Grenoble, France.
(author)
-
Szer, JeffreyPeter MacCallum Canc Ctr, Clin Haematol, Melbourne, Vic, Australia.;Royal Melbourne Hosp, Melbourne, Vic, Australia.
(author)
-
Verdonck, Leo F.Isala Clin, Dept Hematol Oncol, Zwolle, Netherlands.
(author)
-
Aljurf, MahmoudDepartment of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia
(author)
-
van der Poel, MarjoleinMaastricht Univ, Med Ctr, Maastricht, Netherlands.
(author)
-
Litzow, MarkMayo Clin, Div Hematol, Rochester, MN USA.;Mayo Clin, Transplant Ctr, Rochester, MN USA.
(author)
-
Kalaycio, MattCleveland Clin, Hematol & Med Oncol, Transplantat Ctr, Cleveland, OH 44106 USA.
(author)
-
Grunwald, Michael R.Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA.
(author)
-
AngelDiaz, MiguelHosp Infantil Univ Nino Jesus, Dept Hematol Oncol, Madrid, Spain.
(author)
-
Sabloff, MitchellOttawa Hosp Res Inst, Ottawa, ON, Canada.;Univ Ottawa, Dept Med, Div Hematol, Ottawa, ON, Canada.
(author)
-
Kharfan-Dabaja, Mohamed A.Mayo Clin, Div Hematol Oncol, Blood & Marrow Transplantat Program, Jacksonville, FL 32224 USA.
(author)
-
Majhail, Navneet S.Cleveland Clin, Taussig Canc Inst, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA.
(author)
-
Farhadfar, NoshaUniv Florida, Coll Med, Div Hematol Oncol, Gainesville, FL USA.
(author)
-
Reshef, RanColumbia Univ, Med Ctr, Blood & Marrow Transplantat Program, New York, NY USA.;Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY USA.
(author)
-
Olsson, Richard F.Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Karolinska Inst, Dept Lab Med, Stockholm, Sweden(Swepub:uu)riols677
(author)
-
Gale, Robert PeterImperial Coll London, Haematol Res Ctr, Dept Immunol & Inflammat, London, England.
(author)
-
Nakamura, RyotaroCity Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA.
(author)
-
Seo, SachikoDokkyo Med Univ, Dept Hematol & Oncol, Mibu, Tochigi, Japan.
(author)
-
Chhabra, SaurabhMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA.
(author)
-
Hashmi, ShahrukhMayo Clin, Dept Internal Med, Rochester, MN USA.;King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh, Saudi Arabia.
(author)
-
Farhan, ShathaHenry Ford Hosp, Henry Ford Hlth Syst, Bone Marrow Transplant Program, Detroit, MI 48202 USA.
(author)
-
Ganguly, SiddharthaUniv Kansas Hlth Syst, Div Hematol Malignancy & Cellular Therapeut, Kansas City, KS USA.
(author)
-
Nathan, SunitaRush Univ, Med Ctr, Chicago, IL 60612 USA.
(author)
-
Nishihori, TaigaDepartment of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida
(author)
-
Jain, TaniaJohns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA.
(author)
-
Agrawal, VaibhavDivision of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, Indiana
(author)
-
Bacher, UlrikeUniv Bern, Univ Hosp Bern, Inselspital, Dept Hematol, Bern, Switzerland.
(author)
-
Popat, UdayUniv Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Div Canc Med, Houston, TX 77030 USA.
(author)
-
Saber, WaelMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.
(author)
-
Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Div Canc Med, Houston, TX 77030 USA.Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA.
(creator_code:org_t)
Related titles
-
In:Transplantation and Cellular Therapy: Elsevier27:11, s. 921.e1-921.e102666-63752666-6367
Internet link
Find in a library
To the university's database
- By the author/editor
-
Oran, Betul
-
Ahn, Kwang Woo
-
Fretham, Caitrin
-
Beitinjaneh, Ame ...
-
Bashey, Asad
-
Pawarode, Attaph ...
-
show more...
-
Wirk, Baldeep
-
Scott, Bart L.
-
Savani, Bipin N.
-
Bredeson, Christ ...
-
Weisdorf, Daniel
-
Marks, David I.
-
Rizzieri, David
-
Copelan, Edward
-
Hildebrandt, Ger ...
-
Hale, Gregory A.
-
Murthy, Hemant S ...
-
Lazarus, Hillard ...
-
Cerny, Jan
-
Liesveld, Jane L ...
-
Yared, Jean A.
-
Yves-Cahn, Jean
-
Szer, Jeffrey
-
Verdonck, Leo F.
-
Aljurf, Mahmoud
-
van der Poel, Ma ...
-
Litzow, Mark
-
Kalaycio, Matt
-
Grunwald, Michae ...
-
AngelDiaz, Migue ...
-
Sabloff, Mitchel ...
-
Kharfan-Dabaja, ...
-
Majhail, Navneet ...
-
Farhadfar, Nosha
-
Reshef, Ran
-
Olsson, Richard ...
-
Gale, Robert Pet ...
-
Nakamura, Ryotar ...
-
Seo, Sachiko
-
Chhabra, Saurabh
-
Hashmi, Shahrukh
-
Farhan, Shatha
-
Ganguly, Siddhar ...
-
Nathan, Sunita
-
Nishihori, Taiga
-
Jain, Tania
-
Agrawal, Vaibhav
-
Bacher, Ulrike
-
Popat, Uday
-
Saber, Wael
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Hematology
- Articles in the publication
-
Transplantation ...
- By the university
-
Uppsala University
-
Karolinska Institutet